Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $470.56 ($4.5M) on 2026-09-25, disclosed to the SEC on 2026-09-28.
Scheduled sale ($4.5M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $470.56 | 40 | $19K | 0.4% |
| 2 | $471.84 | 200 | $94K | 2.1% |
| 3 | $472.89 | 800 | $378K | 8.4% |
| 4 | $474.15 | 543 | $257K | 5.7% |
| 5 | $475.28 | 1,613 | $767K | 16.9% |
| 6 | $476.13 | 2,744 |
| $1.3M |
| 28.9% |
| 7 | $477.19 | 1,280 | $611K | 13.5% |
| 8 | $478.18 | 1,648 | $788K | 17.4% |
| 9 | $478.95 | 632 | $303K | 6.7% |
| Total | $476.17 avg | 9,500 | $4.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |